Inhibition of Murine AIDS by Reduced Glutathione
- 20 September 1996
- journal article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 12 (14), 1373-1381
- https://doi.org/10.1089/aid.1996.12.1373
Abstract
The imbalance of the redox state in cells and body fluids in HIV-1-infected patients may result in progression of the disease as well as in immunologic disfunctions. In this report, we have evaluated whether the direct administration of high doses of reduced glutathione (GSH) exerts any antiviral activity and/or improves immune functions in a murine immunodeficiency animal model, Intramuscular administration of 50 or 100 mg GSH/mouse for five consecutive days weekly to LP-BM5-infected mice did not show local or systemic signs of acute toxicity, During the first 3 weeks from infection, a period in which clinical signs of disease were not yet detectable, GSH significantly reduced the viral load in lymph nodes and spleen as evaluated by a PCR semiquantitative assay of the proviral DNA content, At 10 weeks a GSH concentration-dependent reduction of splenomegaly, lymphadenopathy and hypergammaglobulinemia was evident in all treated mice. Evaluation of proviral DNA content showed that GSH was effective in inhibiting LP-BM5 infectivity in lymph nodes, spleen, and bone marrow at 100 mg/day, while it was less effective when administered at 50 mg/day, At 10 weeks some animals receiving the highest GSH dose died, thus only the mice receiving 50 mg GSH were followed up to 15 weeks without signs of toxicity, In this case, almost not significant differences among infected untreated or treated animals were observed. Thus, GSH is effective in reducing the proviral DNA load in the first period of infection, These data and the failure of sulfhydril supplementation to further counteract the progression of disease after 10 weeks of infection suggest that combinations of GSH and other antiviral agents may be useful for improving current antiviral therapiesKeywords
This publication has 28 references indexed in Scilit:
- Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replicationAntiviral Research, 1995
- Supplementation ofN-Acetylcysteine Fails to Increase Glutathione in Lymphocytes and Plasma of Patients with AIDSAIDS Research and Human Retroviruses, 1995
- Imbalance between oxidants and antioxidants in the lungs of HIV-seropositive individualsChemico-Biological Interactions, 1994
- Glutathione inhibits replication and expression of viral proteins in cultured cells infected with sendai virusBiochemical and Biophysical Research Communications, 1992
- Glutathione depletion in HIV-infected patientsAIDS, 1992
- Retrovirus-induced immunodeficiency in the mouseAIDS, 1992
- Glutathione deficiency and human immunodeficiency virus infectionThe Lancet, 1992
- N-Acetylcysteine Inhibits Latent HIV Expression in Chronically Infected CellsAIDS Research and Human Retroviruses, 1991
- SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALSThe Lancet, 1989
- Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS).The Journal of Experimental Medicine, 1987